OR WAIT null SECS
March 28, 2019
The collaboration will apply artificial intelligence and machine learning to the development of drugs for treating a range of cancers.
March 27, 2019
Worth up to $605 million, the collaboration will focus on studying a preclinical novel target that could lead to potential new treatments for autoimmune diseases.
March 22, 2019
PDC*line Pharma has entered into a licensing agreement with LG Chem to develop a lung cancer vaccine in Asia.
Cell Mogrify (Mogrify), has been granted funding by the UK’s innovation agency, Innovate UK, to accelerate regenerative cell therapies.
March 21, 2019
Merck KGaA opened a collaborative bio/pharma development facility in Molsheim, France and announced an investment plan through 2025 for its Darmstadt, Germany headquarters.
March 18, 2019
Richard Francis will step down as CEO of Sandoz, effective March 31, 2019.
The companies announced a collaboration to jointly discover and develop treatments to address unmet medical needs in a specific neurological disease.
March 15, 2019
The company received $4.8 million from the Bill & Melinda Gates Foundation to accelerate global health research in the development of vaccines and antibody-based treatments for infectious diseases.
March 12, 2019
The collaboration’s enhanced data exchange combined with advanced analytics are expected to reduce raw material variability and improve biomanufacturing performance reliability.
March 08, 2019
The new facility, located at the company’s headquarters in Pittsburgh, PA, is expected to meet all clinical and commercial development needs of the company’s lead gene therapy program.